Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AVID 317

Next Previous
Drug Profile

AVID 317

Alternative Names: AVID-317

Latest Information Update: 28 Apr 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator AdCure Bio
  • Developer AdCure Bio; Emory University
  • Class Antineoplastics; Immunotherapies; Oncolytic viruses
  • Mechanism of Action Cell death stimulants; Immunologic cytotoxicity; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Cancer; Non-small cell lung cancer

Most Recent Events

  • 28 Apr 2023 No recent reports of development identified for preclinical development in Cancer in USA (IV, Injection)
  • 28 Apr 2023 No recent reports of development identified for preclinical development in Non-small-cell-lung-cancer in USA (IV, Injection)
  • 18 Apr 2019 AdCure Bio has patent protection for penton-mutated, integrin-retargeted adenovirus vectors with reduced toxicity and their use in USA (AdCure Bio pipeline, April 2019)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top